Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2158-3188
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist ; volume:8 ; number:1 ; day:18 ; month:4 ; year:2018 ; pages:1-9 ; date:12.2018
Translational Psychiatry ; 8, Heft 1 (18.4.2018), 1-9, 12.2018
- Creator
-
Gordillo-Salas, Marta
- Contributor
- DOI
-
10.1038/s41398-018-0131-9
- URN
-
urn:nbn:de:101:1-2018062200490331263047
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gordillo-Salas, Marta
- Pilar-Cuéllar, Fuencisla
- Auberson, Yves
- Adell, Albert
- SpringerLink (Online service)
Other Objects (12)
Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
Therapeutic potential of a novel NMDA receptor subunit GluN2B antagonist in a mouse model of autoimmune neuroinflammation
Untersuchungen zu molekularen Interaktions- und Inhibitionsmechanismen von GluN2A- und GluN2B-selektiven NMDA-Rezeptorantagonisten
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
Quinolone bioisosteres of phenolic GluN2B‐selective NMDA receptor antagonists
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Synthese tricyclischer GluN2B-selektiver NMDA-Rezeptor-Antagonisten mit Benzimidazolon-Partialstruktur
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents
Autodisplay der GluN1 und GluN2A Ligandenbindungsdomänen des NMDA-Rezeptors und Untersuchungen zur Membranintegration von Cholesterol-Derivaten
Benzol-Thiophen-Bioisosterie: GluN2B-selektive NMDA-Rezeptor-Antagonisten mit Thienoazepinol-Struktur
Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
Therapeutic potential of a novel NMDA receptor subunit GluN2B antagonist in a mouse model of autoimmune neuroinflammation
Untersuchungen zu molekularen Interaktions- und Inhibitionsmechanismen von GluN2A- und GluN2B-selektiven NMDA-Rezeptorantagonisten
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
Quinolone bioisosteres of phenolic GluN2B‐selective NMDA receptor antagonists
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Synthese tricyclischer GluN2B-selektiver NMDA-Rezeptor-Antagonisten mit Benzimidazolon-Partialstruktur
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents
Autodisplay der GluN1 und GluN2A Ligandenbindungsdomänen des NMDA-Rezeptors und Untersuchungen zur Membranintegration von Cholesterol-Derivaten
Benzol-Thiophen-Bioisosterie: GluN2B-selektive NMDA-Rezeptor-Antagonisten mit Thienoazepinol-Struktur
Unmasking GluN1/GluN3A excitatory glycine NMDA receptors
Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
Therapeutic potential of a novel NMDA receptor subunit GluN2B antagonist in a mouse model of autoimmune neuroinflammation
Untersuchungen zu molekularen Interaktions- und Inhibitionsmechanismen von GluN2A- und GluN2B-selektiven NMDA-Rezeptorantagonisten
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
Quinolone bioisosteres of phenolic GluN2B‐selective NMDA receptor antagonists
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice
Synthese tricyclischer GluN2B-selektiver NMDA-Rezeptor-Antagonisten mit Benzimidazolon-Partialstruktur
GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents
Autodisplay der GluN1 und GluN2A Ligandenbindungsdomänen des NMDA-Rezeptors und Untersuchungen zur Membranintegration von Cholesterol-Derivaten